01:59 PM EDT, 03/18/2025 (MT Newswires) -- Health care stocks were edging lower Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing 0.1%.

The iShares Biotechnology ETF (IBB) fell 1%.

In corporate news, Eli Lilly ( LLY ) is down 0.8% in afternoon trading. Redburn Atlantic adjusted Lilly's price target to $800 from $700, while keeping its neutral rating on the stock.

Can-Fite BioPharma ( CANF ) shares jumped 18% after it said Tuesday that the US Food and Drug Administration has approved the compassionate use treatment with anti-cancer drug Namodenoson for a pancreatic cancer patient in the US.

Harrow (HROW) shares rose 12% after the company said it expects revenue for the quarter ended Dec. 31 of between $65 million and $67 million, exceeding analysts' expectations.